Solid Tumor Research
Blood Cancer Research
Archer is now part of IDT, bringing the future of precision oncology to cancer care. The transaction was completed December 2022. Learn more
in your lab
Archer is now IDT. The combination was completed in December 2022 to bring comprehensive cancer genetics and precision oncology to patients worldwide.
The global fight against cancer requires advanced molecular detection products that are accurate, actionable, easy-to-use and available worldwide.
Our products and services
Investigational Liquid-biopsy Based Cancer Recurrence Detection
Clinical Research Services
We aim to address barriers to bringing precision oncology to patients, anywhere
We are global
We partner with leading
We provide expansive
Follow the Science
Find out more about us and stay in touch